Insulin prices have long been a pain point for diabetics. The big three insulin manufacturers have cut prices across their product lineups, but potential competition from other biosimilar insulins is still in earlier stages of development.Inflation remains a top consumer gripe, but the higher cost of milk and eggs is negligible when compared to insulin. […]
